Drug: REMODULIN Injury: Infusion site erythema Quarter: 2016Q3
Total Records: 75 Number of Pages: 4
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125944101 | REMODULIN | Infusion site erythema | UNITED THERAPEUTICS | 3.38 YR | F | 14 KG | 20160726 | US |
125950011 | REMODULIN | Infusion site erythema | UNITED THERAPEUTICS | 70.71 YR | F | 59 KG | 20160726 | US |
125950351 | REMODULIN | Infusion site erythema | UNITED THERAPEUTICS | 74.76 YR | F | 73 KG | 20160726 | US |
126016922 | REMODULIN | Infusion site erythema | UNITED THERAPEUTICS | 0.00 | F | 52 KG | 20160803 | US |
126029215 | REMODULIN | Infusion site erythema | GILEAD | 47.00 YR | M | 0 | 20160824 | US |
126262682 | REMODULIN | Infusion site erythema | UNITED THERAPEUTICS | 71.19 YR | M | 0 | 20160815 | CA |
126264762 | REMODULIN | Infusion site erythema | GILEAD | 54.00 YR | F | 0 | 20160818 | US |
126342011 | REMODULIN | Infusion site erythema | UNITED THERAPEUTICS | 61.07 YR | F | 50 KG | 20160809 | US |
126516392 | REMODULIN | Infusion site erythema | UNITED THERAPEUTICS | 54.00 YR | F | 0 | 20160825 | US |
126968473 | REMODULIN | Infusion site erythema | UNITED THERAPEUTICS | 0.00 | F | 95 KG | 20160914 | US |
127097051 | REMODULIN | Infusion site erythema | UNITED THERAPEUTICS | 68.52 YR | M | 54 KG | 20160902 | JP |
127206662 | REMODULIN | Infusion site erythema | GILEAD | 11.00 YR | F | 0 | 20160912 | US |
127581552 | REMODULIN | Infusion site erythema | UNITED THERAPEUTICS | 63.60 YR | F | 50 KG | 20160928 | US |
127848222 | REMODULIN | Infusion site erythema | GILEAD | 57.00 YR | F | 48 KG | 20160930 | US |
1161400910 | REMODULIN | Infusion site erythema | ACTELION | 66.00 YR | F | 0 | 20160826 | US |
Total Records: 75 Number of Pages: 4